NYSE:DDL
NYSE:DDLConsumer Retailing

Discover 3 Growth Companies With Insider Ownership Expecting Up To 170% Earnings Growth

The U.S. stock market has recently experienced a downturn, with major indices like the Dow Jones, S&P 500, and Nasdaq all declining due to concerns over AI-related valuations and strategic corporate partnerships. In this environment of uncertainty, growth companies with high insider ownership can offer a unique advantage as they often indicate strong confidence from those who know the business best.
NasdaqCM:ZENV
NasdaqCM:ZENVSoftware

Top Penny Stocks To Watch In November 2025

As the U.S. market experiences a downturn with major indexes like the Dow Jones dropping significantly, investors are seeking opportunities that can weather current uncertainties. Penny stocks, though an older term, remain relevant for those looking to invest in smaller or newer companies that might offer unique growth prospects. By focusing on penny stocks with strong financial health, investors can potentially uncover hidden gems amidst market volatility.
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Assessing Madrigal Pharmaceuticals After FDA Approval and an 82% Share Price Surge

Wondering if Madrigal Pharmaceuticals could be a smart buy at today's prices? You are not alone, especially with so much market chatter about where it's really worth putting your money right now. The stock has been on a serious roll, jumping 11.6% in the last week, 26.1% over the past month, and an eye-catching 76.4% year to date. This has culminated in an impressive 82.4% rally over the past year. Much of this momentum came after Madrigal received FDA approval for its liver disease drug,...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

How Higher Revenue and Rising Short Interest at Alliant Energy (LNT) Have Changed Its Investment Story

Alliant Energy Corporation recently announced its third-quarter 2025 earnings, reporting year-over-year revenue growth to US$1.21 billion, but a decrease in quarterly net income to US$281 million, alongside a narrowed 2025 earnings forecast and an increase in 2026 dividend guidance. An interesting insight is that despite higher revenues and a raised dividend target, a sharp increase in short interest suggests heightened investor scrutiny and mixed expectations about the company’s future...
NYSE:HUBB
NYSE:HUBBElectrical

Should Investors Revisit Hubbell After This Week’s 9% Dip?

Ever wondered if Hubbell’s current share price actually lines up with its real value? If you’re weighing up whether now is the time to buy in or hold off, you’re in the right place. After racing to new highs earlier in the year, Hubbell’s shares have pulled back in the short term, with a 9.0% dip this week and essentially flat performance so far in 2024. Several analyst upgrades and sector-wide optimism about U.S. infrastructure spending have put the spotlight on Hubbell lately, fueling both...
NasdaqGM:JANX
NasdaqGM:JANXBiotechs

Is Progress in Prostate Cancer Therapies and Shrinking Losses Altering the Investment Case for Janux Therapeutics (JANX)?

Janux Therapeutics reported a net loss of US$24.31 million for the third quarter of 2025, an improvement from the US$28.06 million loss in the same period last year, alongside updates on continued progress in its oncology pipeline. Heightened interest centered on Janux’s prostate cancer program, as early clinical data for T cell-engaging therapies JANX007 and JANX008 indicated improved efficacy and durable responses, prompting renewed analyst confidence ahead of the expected mature Phase 1...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Millicom (TIGO) Is Up 9.6% After Q3 Results Beat With Acquisitions Boosting Earnings

Millicom International Cellular reported third-quarter 2025 results showing net income of US$195 million on sales of US$1.42 billion, with strong improvements in earnings per share compared to the same period last year. Operating performance benefited from recent acquisitions in Uruguay and Ecuador, and financial results exceeded expectations for both the quarter and year-to-date periods. We'll examine how Millicom's sharply higher profitability and recent acquisitions could reshape its...
NasdaqCM:SUPX
NasdaqCM:SUPXConsumer Services

Could Dr. Huang’s Leadership Signal a New Strategic Chapter for SuperX AI Technology (SUPX)?

SuperX AI Technology Limited has announced that Dr. Chenhong Huang will become Chairman of the Board, Executive Director, and CEO effective December 1, 2025, bringing with him over 30 years of leadership across major global technology firms. This leadership transformation aligns with SuperX's ambitions to scale its modular AI factory and expand proprietary infrastructure solutions on a global stage. We'll explore how Dr. Huang’s extensive experience in scaling complex technology operations...
NYSE:AWK
NYSE:AWKWater Utilities

Did a $1.2 Billion Infrastructure Rate Hike Just Shift American Water Works Company's (AWK) Investment Narrative?

Earlier this month, American Water Works Company announced that its subsidiary, Pennsylvania-American Water, filed a request with the Pennsylvania Public Utility Commission to increase water and wastewater rates to support roughly US$1.2 billion in infrastructure investments from June 2025 through mid-2027. This request, which includes a proposed US$14 monthly increase for typical customers and a pilot program to aid low-income renters, could meaningfully affect the company's future capital...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Is Expedia Still a Bargain After Recent Tech Partnerships and 31% Share Surge?

Wondering whether Expedia Group is still a good deal after its meteoric run? You are not alone. Getting a handle on its true value could make all the difference for your next move. The stock has seen a roller coaster recently, surging 13.7% over the past month and climbing an impressive 31.7% year-to-date. However, it dipped 8.9% in the last week. Recent headlines highlight Expedia Group's new tech partnerships and a continued focus on streamlining its travel booking platforms. These...
NYSE:RMD
NYSE:RMDMedical Equipment

Will ResMed’s (RMD) Margin Expansion Define Its Role as a Defensive Portfolio Anchor?

Recent analyst commentary highlights ResMed's strong fundamentals, including expanding margins, robust cash flow, and resilience against economic downturns, as key reasons for optimism about the company's future prospects. This focus on financial stability and operational efficiency has drawn increased investor attention, especially for those seeking portfolio protection during uncertain economic conditions. We'll explore how ResMed's proven financial resilience and operational strengths may...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

A Look at Xometry's Valuation Following Strong Q3 Revenue Growth and Raised Guidance

Xometry (XMTR) caught investor attention after reporting a big jump in third quarter revenue and raising its full-year guidance. Sales climbed 23% compared to last year, which highlights strong momentum for the company. See our latest analysis for Xometry. It has been a rollercoaster stretch for Xometry, with the share price jumping nearly 20% over the past month and extending its year-to-date gain to 35%. The company has also experienced sharp pullbacks in recent days as some investors...
NasdaqCM:CDTX
NasdaqCM:CDTXBiotechs

Cidara Therapeutics Valuation After Clinical Trial Updates and 110% Weekly Price Surge

Ever wondered if Cidara Therapeutics could be hiding serious value, or if its recent buzz is already baked into the price? You are not alone, and a closer look may reveal more than first impressions suggest. The stock has delivered an eye-watering 110% gain in the last week alone, and is up 1356.6% over the past year, raising both hopes for continued upside and questions about risk. Recent news has fueled the rally, with fresh clinical trial updates and strategic partnerships sending signals...
NYSE:UAA
NYSE:UAALuxury

The Bull Case for Under Armour (UAA) Could Change Following Curry Brand Separation and Restructuring Actions

Under Armour announced in November 2025 that it will separate the Curry Brand from its business and expand restructuring efforts, updating fiscal 2026 guidance to reflect an operating loss of US$56 million to US$71 million with related charges increasing to US$255 million. This move marks the end of a 13-year partnership with NBA star Stephen Curry and signals a major brand realignment as Under Armour shifts focus to its core brand and operational changes. We'll look at how the separation of...
NYSE:TKO
NYSE:TKOEntertainment

Three Stocks Believed To Be Trading Below Their Estimated Intrinsic Values

As the U.S. stock market experiences fluctuations with major indexes closing sharply lower, investors are keenly watching earnings reports from tech and retail giants. In such volatile times, identifying stocks that are believed to be trading below their estimated intrinsic values can offer potential opportunities for investors seeking value amidst market uncertainty.
NasdaqGS:PBYI
NasdaqGS:PBYIBiotechs

1stdibs.Com And 2 Other Penny Stocks To Watch Closely

The U.S. stock market recently experienced a sharp decline, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant losses. Amidst this volatility, investors often seek out unique opportunities that may not be immediately apparent in larger, more established companies. Penny stocks, though considered somewhat outdated as a term, still represent an intriguing investment area for those looking to explore smaller or newer companies with potential growth prospects...
NYSE:INGR
NYSE:INGRFood

Top Dividend Stocks To Consider In November 2025

As the U.S. stock market experiences significant fluctuations, with major indexes closing sharply lower and tech stocks facing volatility, investors are increasingly looking for stability in their portfolios. In such an environment, dividend stocks can offer a reliable income stream and potential for long-term growth, making them an attractive consideration amidst current market uncertainties.